Disease Areas:
Cystic fibrosisDevice Types:
AlphaThis open-label, randomized, pilot crossover trial examined the feasibility of conducting a clinical trial of nasal high-flow therapy as an adjunct to exercise in 23 adult patients with cystic fibrosis and severe lung disease. As part of the study, lung function testing was undertaken 30 minutes before and after a 6MWT using a Vitalograph Alpha spirometer.
